ORKA
Oruka Therapeutics, Inc.
Latest Form 4:Sale$783KbyGoncalves Joana (Chief Medical Officer) · filed Aug 17, 2026
Oruka Therapeutics, Inc. (ORKA) has 37 SEC Form 4 filings (126 transaction rows) in the rolling window, disclosed by 7 distinct insiders. Most recent filing: Aug 25, 2026.
The most active filer is Chief Medical Officer Goncalves Joana with 9 filings. Insiders have net sold $322.1M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Lawrence Otto Klein
- Employees:68
- HQ:Menlo Park, CA, US
- IPO:1997-08-08
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$323.1M
reported sales (SEC code S)
Unique Insiders
7
in the rolling window
Market Cap
$6.0B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| Chief Medical Officer | Sale | 7,000 | $783K | Aug 17 | SEC ↗ | |
| General Counsel | Sale | 52,000 | $5.6M | Aug 14 | SEC ↗ | |
| Senior Vice President, Finance | Sale | 10,000 | $1.1M | Aug 14 | SEC ↗ | |
| Chief Medical Officer | Sale | 7,000 | $604K | Jul 15 | SEC ↗ | |
| Senior Vice President, Finance | Sale | 9,999 | $846K | Jul 13 | SEC ↗ | |
| Director, 10% Owner | Sale | 3,553,410 | $300.0M | Jul 2 | SEC ↗ | |
| Chief Operating Officer | Sale | 5,000 | $472K | Jul 1 | SEC ↗ | |
| Senior Vice President, Finance | Sale | 1,587 | $128K | Jun 22 | SEC ↗ | |
| Senior Vice President, Finance | Sale | 9,459 | $660K | Jun 15 | SEC ↗ | |
| Senior Vice President, Finance | Sale | 395 | $28K | Jun 15 | SEC ↗ | |
| Chief Medical Officer | Sale | 7,947 | $551K | Jun 15 | SEC ↗ | |
Klein Lawrence OttoFirst in 3 months | Chief Executive Officer | Sale | 1,729 | $120K | Jun 15 | SEC ↗ |
| Chief Operating Officer | Sale | 600 | $42K | Jun 15 | SEC ↗ | |
Quinlan Paul TFirst in 3 months | General Counsel | Sale | 733 | $51K | Jun 15 | SEC ↗ |
| Director | Sale | 22,417 | $1.6M | Jun 12 | SEC ↗ | |
| Director | Sale | 12,583 | $882K | Jun 12 | SEC ↗ | |
| Director | Sale | 105,000 | $6.2M | May 22 | SEC ↗ | |
| Senior Vice President, Finance | Sale | 10,290 | $608K | May 18 | SEC ↗ | |
| Chief Medical Officer | Sale | 7,000 | $433K | May 16 | SEC ↗ | |
| Chief Operating Officer | Sale | 5,000 | $319K | May 1 | SEC ↗ | |
| Chief Medical Officer | Sale | 7,000 | $463K | Apr 15 | SEC ↗ | |
| Chief Medical Officer | Sale | 7,641 | $313K | Mar 17 | SEC ↗ | |
| Chief Operating Officer | Sale | 600 | $25K | Mar 17 | SEC ↗ | |
Agarwal ArjunFirst filing | Senior Vice President, Finance | Sale | 395 | $16K | Mar 17 | SEC ↗ |
Klein Lawrence OttoFirst filing | Chief Executive Officer | Sale | 1,729 | $71K | Mar 17 | SEC ↗ |
Quinlan Paul TFirst filing | General Counsel | Sale | 733 | $30K | Mar 17 | SEC ↗ |
| Chief Operating Officer | Sale | 5,000 | $168K | Mar 2 | SEC ↗ | |
| Chief Medical Officer | Sale | 7,000 | $227K | Feb 17 | SEC ↗ | |
| Chief Medical Officer | Sale | 7,000 | $223K | Jan 16 | SEC ↗ | |
Sandler Laura LeeFirst filing | Chief Operating Officer | Sale | 13,000 | $371K | Jan 2 | SEC ↗ |
Goncalves JoanaFirst filing | Chief Medical Officer | Sale | 7,000 | $214K | Dec 19 | SEC ↗ |
Related companies
Oruka Therapeutics, Inc. is in the Healthcare sector.